1. Home
  2. GEVO vs PRQR Comparison

GEVO vs PRQR Comparison

Compare GEVO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

N/A

Current Price

$2.37

Market Cap

568.2M

Sector

Industrials

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.49

Market Cap

167.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GEVO
PRQR
Founded
2005
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
568.2M
167.5M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
GEVO
PRQR
Price
$2.37
$1.49
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$6.42
$7.67
AVG Volume (30 Days)
3.7M
273.3K
Earning Date
03-05-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
58.82
N/A
EPS
N/A
N/A
Revenue
$711,000.00
N/A
Revenue This Year
$19.44
$18.88
Revenue Next Year
$5.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$1.08
52 Week High
$2.95
$3.10

Technical Indicators

Market Signals
Indicator
GEVO
PRQR
Relative Strength Index (RSI) 63.77 40.14
Support Level $2.26 $1.33
Resistance Level $2.46 $1.58
Average True Range (ATR) 0.15 0.11
MACD 0.01 -0.03
Stochastic Oscillator 75.97 5.56

Price Performance

Historical Comparison
GEVO
PRQR

About GEVO Gevo Inc.

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: